TNF-α induces vasoconstriction, and is involved in micro vascular protein leakage and hypertriglyceridemia. 11 Rise in TNF-α level is found in patients with preeclampsia. [11] [12] [13] [14] No study has reported comparison of angiogenic factor (PlGF) and inflammatory factor (TNF-α) between early onset and late onset preeclampsia in Indonesia. This is seen as an interesting topic, as the result would bring us closer to understand more about some factors to predict preeclampsia.
METHOD
This was a cross-sectional analytic comparative study, comparing serum level of PlGF and TNF-α between groups with early and late onset preeclampsia. Each group consisted of 32 subjects with gestational age of 20 weeks or more, single live fetus, who regularly have antenatal care, not showing any signs of infection, and clinically diagnosed with preeclampsia before and after the 34 th gestational week from the last menstrual period, not having any history of hypertension nor kidney or liver disorder before pregnancy, and presented to Dr. Hasan Sadikin Hospital or its district hospitals in September -November 2012.
Five ml of blood sample were collected by cubital vein phlebotomy. The blood was stored for ±30 minutes in vacutainer, to be centrifuged in 3000 rpm thereafter for 10 minutes. The serum were stored in plastic tubes at -20°C. Then the serum level of PlGF and TNF-α were measured by ELISA method. The results recorded were serum level of PlGF in pg/ml and serum level of TNF-α in pg/ml.
RESULT
Characteristics of subjects in both groups are analyzed by Mann-Whitney test for numerical data and Kolmogorov-Smirnov test for categorical data. They are maternal age (in categories of <20 year old, 20-35 year old, and >35 year old), parity (in categories of 0, 1-3, and 4+), and BMI before pregnancy (with mean of 22.2538±1.19469 in subjects with early-onset preeclampsia, and 23.1509± 1.90633 in those having late-onset preeclampsia). Both groups do not show any significant difference in maternal age (p=0.627), parity (p=1.000), or BMI before pregnancy (p=0.073).
Saphiro-Wilk test for normality was done on the PlGF and TNF-α serum level from the 64 subjects. p value of <0.05 shows the data from both groups are not normally distributed. Thus, the data was analyzed with Mann-Whitney nonparametric test. SPSS version 18.0 for windows was used in analyzing data. Table 1 shows PlGF serum level of the group with early-onset preeclampsia compared with lateonset preeclampsia. The level is significantly lower in the group with early onset preeclampsia. Whereas Table 2 shows a nonsignificant result (p>0.05), therefore TNF-α serum level of both groups is not significantly different.
DISCUSSION
The two-stage model of preeclampsia proposes that the first stage of preeclampsia is dominantly caused by poorly perfused placentation. This condition explains the lower PlGF level in the early onset compared with late onset preeclampsia, where greater extent of placental damage takes place. 15 A study done by Ogge in 2011 explained that placental damage in early onset preeclampsia is histopathologically more extensive due to the greater degree of lesion following the wider infarction, and chronic inflammation such as vasculitis and villitis, which causes decidual arteriopathy and further re-
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Obstet Gynecol | duction of villi surface volume. In early onset preeclampsia, trophoblastic inadequate invasion to maternal spiral artery accounts for reduced perfusion to umbilical artery, which causes fetal restriction. 16 The significantly different level of PlGF shown in this study may be affected by some factors, one of them is the very low level of which in early onset preeclampsia may follow more damage in placenta, although histopathological examination was not performed in this study. Furthermore, the PlGF serum level in late onset preeclampsia is higher, some approaching the level of which in normal pregnancy, because of the minimally damaged or even intact placenta. 2, 16, 17 Compared with the other angiogenic factors, PlGF serum level is superior for detecting preeclampsia, as PlGF is placental specific. 15, 18 This study reports a non-significant difference in TNF-α serum level. This result can be explained by theory of pathogenesis proposed by Roberts, in which endothelial dysfunction following the increased level of cytokine, such as TNF-α, is the second stage of preeclampsia. Placental abnormalities in the first stage may induce release of placental factors into maternal circulation. This leads to glomerular endotheliosis, vascular permeability, and inflammatory response marked by increased level of cytokines such as TNF-α, further causing various organ damage by mechanism of hypoperfusion. 15 According to former studies by Ogge and Huppertz, placental abnormality in preeclampsia may have occurred in the first trimester, even when clinical manifestations are not observable yet, leaving a more extensive placental damage. 16, 17 Earlier hypoxia condition happened in placenta leads to earlier placental damage, thus cytokine expression ensues earlier. This is consistent with a former study by Haider. 5 Referring to the study by Robert JM and Hubel CA in 2009, the second stage of preeclampsia may occur even without the first stage, when maternal risk factors such as obesity and diabetes were clinically significant to generate clinical manifestations of preeclampsia syndrome. 15 Founds reported an enhancement of TNF-α production by adipocytes in preeclamptic women. 19 Further study including objective tests for kidney and liver function in TNF-α measurement, or investigating other factors to predict preeclampsia, is encouraged.
CONCLUSION
Serum level of PlGF in early-onset preeclampsia is lower than in late onset preeclampsia. There is no significant difference of TNF-α serum level between the early and late onset preeclampsia.
